Titania and silica nanoparticles coupled to Chlorin e6 for anti-cancer photodynamic therapy
Photodynamic therapy (PDT) has emerged as an alternative and promising minimally invasive treatment modality for certain types of cancers. For example, in dermatology, PDT is gradually becoming the reference treatment for actinic keratoses (KA), superficial basal cell carcinomas and Bowen's disease [1]. In ophthalmology, PDT with Visudyne ® has been very popular in the treatment of patients with Age-related macular degeneration [2]. In urology, the French company Steba-Biotech [3] has developed Tookad® as a new PS for the treatment of prostate cancer.
Source: Photodiagnosis and Photodynamic Therapy - Category: Laser Surgery Authors: Zahraa Youssef, Val érie Jouan-Hureaux, Ludovic Colombeau, Philippe Arnoux, Albert Moussaron, Francis Baros, Joumana Toufaily, Tayssir Hamieh, Thibault Roques-Carmes, Céline Frochot Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Biotechnology | Cancer | Cancer & Oncology | Carcinoma | Dermatology | France Health | Laser Surgery | Nanotechnology | Opthalmology | Prostate Cancer | Skin | Urology & Nephrology